trans-4-Methylcyclohexanamine, 100mg

N~1~,N~1~-dimethyl-1-(1-methyl-1H-pyrrol-2-yl)ethane-1,2-diamine, 95.0%, 250mg

9-(Naphthalen-2-yl)anthracene, 98%, 100g

2-Chloro-4-(trifluoromethyl)benzaldehyde, 95.0%, 1g

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-((tert-butyldimethylsilyl)oxy)pyrrolidine-2-carboxylic acid, 97%, 250mg

Éster metílico del ácido docosahexaenoico, ROTICHROM GC, 50 mg, envase de vidrio

2-piperidinomethyl-3',4',5'-trifluorobenzophenone, 97.0%, 1g

3-Methylenepiperidin-2-one, 95%, 250mg

1-Benzyl 3-methyl 6-(hydroxymethyl)piperidine-1,3-dicarboxylate, 97%, 1g

2-Bromo-4-isopropylphenyl isothiocyanate, 97.0%, 1g

N-[1-Hydroxy-2-(4-methylphenyl)-2-oxoethyl]-propionamide, 25mg

3-(Trifluoromethyl)benzoic Acid>98.0%(GC)(T)5g